NCT04940572View on ClinicalTrials.gov

Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 26, 2021

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2025

Conditions
Wolfram Syndrome
Interventions
DRUG

Depakine

Refer to arm description.

Trial Locations (2)

75015

RECRUITING

HEGP, Paris

04009

RECRUITING

Centro periférico de Especialidades de Almería, Almería

Sponsors

Collaborators (1)

Genethon
All Listed Sponsors
collaborator

Genethon

OTHER

lead

Centre d'Etude des Cellules Souches

OTHER

NCT04940572 - Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome | Biotech Hunter | Biotech Hunter